Search Results | Litt's Drug Eruption and Reaction Database

Skip to main content

Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.Litt's Development Team

Log in

Menu

Login

Home
About About
Alerts
Litt’s App
Contact Us
Help
Subscribe Subscribe
- Individual Subscription
- Institutional Subscription

Drugs belonging to restart save

class – Antiparkinsonian agent – 14 items found

Search:

show all
0–9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Amantadine Compare:

Apomorphine Compare:

Entacapone Compare:

Levodopa Compare:

Opicapone Compare:

Pramipexole Compare:

Procyclidine Compare:

Rasagiline Compare:

Ropinirole Compare:

Rotigotine Compare:

Safinamide Compare:

Selegiline Compare:

Tolcapone Compare:

Trihexyphenidyl Compare:

Loading more results

No more results to show

Adverse reactions attributed to entire drug class 'Antiparkinsonian agent'

Please login to view adverse reactions.

Cardiovascular adverse effect (includes major adverse cardiovascular events (MACE))

(2026): Mu X+, Basic Clin Pharmacol Toxicol 138(6), e70242 [REVIEW] (pharmacovigilance / pharmacoepidemiology)
(2026): Qian B+, Cardiol Rev Apr, Online ahead of print [REVIEW]

Saved Searches Watched Drugs

Litt's app available free to subscribers

Search drug eruptions and reactions data anytime, anywhere

With full access to drug profiles, reactions and linked PubMed abstracts through your smart phone! If you subscribe via your institution and do not have a personal login you will need to register on the website to create a login for the app.

Help
Terms & Conditions
Privacy
Disclaimer
Contact us

© 2026 Taylor & Francis Group, LLC. All Rights Reserved.